The Drugs Controller General of India (DCGI) is a key regulatory authority. It oversees the approval and regulation of pharmaceuticals and medical devices. The DCGI ensures that drugs are safe and effective for public use. It plays a vital role in public health. The organisation also monitors clinical trials and enforces compliance with drug laws. Its work is crucial for healthcare in India.
The recent launch of the NANDI (NOC Approval for New Drug and Inoculation System) Portal marks a significant milestone in the veterinary sector in India. Developed by the...
Researchers in India are working on developing an affordable treatment for a rare and incurable genetic disorder called Duchenne Muscular Dystrophy (DMD) which affects over 5 lakh people...
Pharmaceutical company Hetero announced on December 26th that it has received World Health Organization Prequalification of Medicines Programme (WHO PQ) approval for its generic version of Covid-19 oral...
Bharat Biotech's intranasal COVID-19 vaccine, also known as iNCOVACC or BBV154, has been approved for use in India as a booster dose for those over 18 years of...
The Directorate General of Civil Aviation (DGCA), the country's civil aviation regulator, has notified guidelines for airlines and other aircraft operators for the transportation of Covid-19 vaccines. Key...
India has recently given emergency-use approval to two COVID-19 vaccines- 'Covishield' and 'Covaxin'. Both the vaccines were recommended by the Subject Expert Committee (SEC) of DGCI (Drug Controller...
India's first indigenously developed pneumococcal vaccine 'Pneumosil' has been unveiled by the Serum Institute of India (SII). The Pune-based SII is the largest vaccine manufacturer in terms of...
In normal times, drugs and vaccines required to be tested and approved by regulatory authorities of a country before they can be commercially used. But Emergency Use Authorisation...
The New Drugs and Clinical Trials Rules 2019 has been issued by the Union Ministry of Health and Family welfare in March 2019. It has regulations over the...
Sputnik V vaccine is the first registered vaccine of the world against COVID-19 based on the human adenoviral vector-based platform. The post-registration clinical trial of the vaccine is...
